ADC Linker

NO2-SPP-sulfo is a cleavable linker designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates the targeted delivery of therapeutic agents, enhancing the efficacy and safety of drug formulations. Its unique properties enable selective release of the drug component in the target cells, making it a vital tool in cancer research and therapeutic development.

N-Succinimidyloxycarbonylpropyl methanethiosulfonate is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). It features a methanethiosulfonate moiety that facilitates stable attachment between antibodies and drug payloads, ensuring effective delivery and enhanced therapeutic efficacy. This compound is particularly valuable in bioconjugation applications aimed at targeted cancer therapies and other therapeutic strategies.

PDB-Pfp is a cleavable linker designed for the formation of antibody-drug conjugates (ADCs). It facilitates the selective release of the cytotoxic drug upon internalization by target cells, enhancing the therapeutic efficacy of ADCs. This reagent is essential for researchers developing targeted cancer therapies and studying the mechanisms of antibody-drug conjugate action.

Mal-amido-PEG8-val-gly-PAB-OH is a cleavable polyethylene glycol (PEG) linker designed for use in the development of antibody-drug conjugates (ADCs). This 8-unit PEG structure enhances solubility and stability while facilitating controlled drug release. Its applications include targeted delivery of cytotoxic agents to specific cells, making it a valuable tool for cancer therapeutics and research in drug conjugation technologies.

Propargyl-PEG9-bromide is a PEG-based linker utilized in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This non-cleavable linker facilitates the targeted delivery of therapeutics through its unique click chemistry capabilities, featuring an alkyne group suitable for copper-catalyzed azide-alkyne cycloaddition (CuAAc). Its applications extend to enhancing drug efficacy and specificity in chemical biology and therapeutic development.

Ald-Ph-amido-PEG11-NH-Boc is a non-cleavable 11-unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the stable attachment of cytotoxic agents to antibodies, enhancing the therapeutic efficacy of ADCs while maintaining their specificity towards target cells. Its unique structure supports improved solubility and biocompatibility, making it a valuable tool in cancer research and drug development.

Fmoc-Ala-Ala-Asn-PABC-PNP is a peptide-cleavable linker designed for antibody-drug conjugates (ADCs). This compound features a unique functionality that facilitates the release of cytotoxic drugs upon enzymatic cleavage. It is ideal for applications in targeted cancer therapy research, enabling the development of more effective and safer treatment options through selective drug delivery.

Boc-Aminooxy-PEG2-bromide is a cleavable 2 unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This linker facilitates the attachment of drug molecules to antibodies, promoting targeted delivery and enhanced therapeutic efficacy. Its application is critical in the development of innovative ADCs for cancer therapy and other diseases, enabling selective release of cytotoxic agents in tumor microenvironments.

N-(Iodoacetamido)-Doxorubicin is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This reagent enables the targeted delivery of doxorubicin, a potent chemotherapeutic agent, by covalently binding to antibodies, thereby enhancing the therapeutic efficacy and specificity of the conjugate. Its unique bioconjugation properties make it a valuable tool in cancer research, particularly in the development of innovative ADC therapies.

THP-SS-PEG1-Tos is a cleavable linker designed for use in antibody-drug conjugates (ADCs), featuring a polyethylene glycol (PEG) unit. This linker facilitates the selective release of cytotoxic agents in targeted therapies, enhancing the therapeutic index of ADCs. Its unique properties make it suitable for applications in cancer research and drug development, providing a versatile tool for improving the efficacy of antibody-mediated treatments.

Fmoc-Val-Ala-Gly is a cleavable linker specifically designed for antibody-drug conjugate (ADC) applications. This compound facilitates conjugation with antibodies, such as Trastuzumab, enabling the targeted delivery of cytotoxic agents to cancer cells. Its structural attributes promote effective release of the drug upon internalization, making it a valuable reagent for ADC development in cancer research.

Tr-PEG5-OH is a non-cleavable polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). Comprising five PEG units, this versatile linker facilitates the conjugation of antibodies to cytotoxic drugs, enhancing the therapeutic efficacy and selectivity of ADCs. Additionally, Tr-PEG5-OH serves as a PEG-based PROTAC linker, enabling the development of proteolysis-targeting chimeras for targeted protein degradation studies.

Fmoc-Gly3-Val-Cit-PAB-PNP is a cleavable four-unit PEG linker designed for the synthesis of antibody-drug conjugates (ADCs). This linker is engineered to enhance the stability and efficacy of ADCs, facilitating precise drug delivery to targeted cells. Its unique structure allows for controlled release of the cytotoxic agent, making it suitable for applications in cancer therapeutics and targeted drug delivery research.

m-PEG7-CH2CH2CHO is a non-cleavable linker primarily designed for the development of antibody-drug conjugates (ADCs). This PEG-based compound facilitates efficient conjugation of cytotoxic payloads to antibodies, enhancing targeted delivery and therapeutic efficacy. Additionally, m-PEG7-CH2CH2CHO serves as a versatile linker in the synthesis of PROTACs, supporting research into targeted protein degradation mechanisms.

Azidoethyl-SS-propionic acid is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features an azide group that facilitates click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it can participate in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN functionalized compounds, making it valuable for targeted drug delivery and bioconjugation applications in research.

m-PEG4-Boc is a cleavable polyethylene glycol (PEG) linker with four ethylene glycol units, designed for use in the synthesis of antibody-drug conjugates (ADCs) and Proteolysis Targeting Chimeras (PROTACs). This versatile linker facilitates the development of ADCs by enabling site-specific conjugation, while also serving as a crucial component in PROTAC design for targeted protein degradation. Its functional properties contribute to the effectiveness and stability of various bioconjugates in chemical biology research.

Fmoc-PEG4-Ala-Ala-Asn-PAB is a cleavable ADC linker composed of a 4-unit polyethylene glycol (PEG) backbone. This reagent facilitates the synthesis of antibody-drug conjugates (ADCs) by enabling the selective attachment of therapeutic agents to antibodies. Its design contributes to improved solubility and stability of ADCs, making it a valuable tool in targeted drug delivery research and development.

Mal-C5-N-bis(PEG2-C2-acid) is a versatile linker specifically designed for the formulation of antibody-drug conjugates (ADCs). This compound facilitates efficient conjugation through its maleimide functionality, ensuring stable attachment to thiol groups present on antibodies. Its unique PEG-based structure enhances solubility and biocompatibility, making it ideal for improving the pharmacokinetic properties of ADCs in various therapeutic research applications.

Ald-Ph-amido-PEG11-C2-NH2 is a non-cleavable 11-unit polyethylene glycol (PEG) linker designed for use in antibody-drug conjugate (ADC) synthesis. This versatile linker facilitates the stable attachment of cytotoxic agents to antibodies, enhancing the therapeutic efficacy of ADCs while minimizing systemic toxicity. Its design is optimized for applications in targeted cancer therapy research, allowing for precise drug delivery to malignant tissues.

LC-SMCC is a versatile ADC linker that facilitates the conjugation of drugs to antibodies, enabling the development of antibody-drug conjugates (ADCs). Its primary mechanism involves the formation of stable thioether bonds through the reaction with thiol groups on the antibody. This compound is crucial for enhancing targeted delivery and efficacy of therapeutic agents while minimizing systemic toxicity, making it an essential tool in cancer research and drug development.

MC(C5)-Val-Cit is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). It facilitates the selective release of cytotoxic agents upon internalization, ensuring targeted delivery to tumor cells. This linker is particularly valuable for researchers developing ADCs to enhance therapeutic efficacy while minimizing off-target effects.

GDP-L-Fuc-PEG4-BCN is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This linker facilitates the efficient conjugation of antibodies with cytotoxic drugs, enhancing targeted delivery to tumor cells. Its incorporation allows for controlled release of therapeutic agents upon internalization, making it suitable for cancer research and the development of innovative ADC therapeutics.

Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates the targeted delivery of cytotoxic agents by covalently attaching them to antibodies, ensuring selective action on tumor cells. Its unique structure allows for controlled release of the drug in the target environment, making it a key component in ADC development and research applications focused on cancer therapeutics.

1,6-Bis(mesyloxy)hexane is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). It facilitates the precise attachment of therapeutic agents to antibodies, enhancing targeted delivery in cancer therapy. Its design allows for effective cleavage in the target environment, thus promoting the selective release of cytotoxic drugs and improving therapeutic efficacy in research applications.

Tup hydrochloride is a cleavable linker for antibody-drug conjugates (ADCs). It facilitates the selective release of cytotoxic agents in targeted therapy, enhancing therapeutic efficacy by ensuring the release of the drug in the vicinity of the target cells. This compound is particularly useful in the development and optimization of ADCs for cancer treatment research.

NO2-SPDB-sulfo is a cleavable antibody-drug conjugate (ADC) linker designed for efficient conjugation of cytotoxic drugs to antibodies. This linker facilitates the selective release of the drug in the target environment, promoting enhanced therapeutic efficacy while minimizing off-target effects. It is widely utilized in research and development of ADCs for targeted cancer therapy.

MP-Ala-Ala-PAB is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents to cancer cells, enhancing therapeutic efficacy while minimizing off-target effects. Its ability to be cleaved under specific conditions makes it a valuable component in the development of effective ADC formulations in cancer research.

N-Cbz-glycyl-glycyl-D-phenylalanine functions as a cleavable linker for antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents to cancer cells, enhancing therapeutic efficacy while minimizing systemic toxicity. Its design allows for selective cleavage in the presence of tumor-specific conditions, making it a valuable tool in cancer research and ADC development.

MC-PEG2-C2-NHS ester is a non-cleavable 2-unit polyethylene glycol (PEG) linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This linker facilitates the site-specific attachment of therapeutic agents to antibodies, enhancing the stability and pharmacokinetics of the resulting conjugates. Its application is critical in developing targeted therapies for cancer and other diseases, allowing for improved delivery and efficacy of biologic drugs.

STI-8811 is a highly efficient drug-linker designed for the synthesis of antibody-drug conjugates (ADCs). It facilitates the covalent attachment of therapeutic agents to antibodies, enhancing the specificity and efficacy of targeted cancer treatments. This linker is essential for researchers focused on developing innovative ADC formulations that can improve therapeutic outcomes in oncology.

Propargyl-PEG24-acid is a versatile ADC linker that features a polyethylene glycol (PEG) chain. This compound facilitates the synthesis of antibody-drug conjugates (ADCs) by providing a stable yet flexible connection between the antibody and cytotoxic agents. Its applications in drug development include enhancing therapeutic efficacy while minimizing off-target effects, making it a valuable tool for researchers in the field of targeted cancer therapies.

Aminooxy-PEG2-alcohol serves as a non-cleavable linker designed for antibody-drug conjugates (ADCs). This 2 unit polyethylene glycol (PEG) linker facilitates the efficient conjugation of antibodies to cytotoxic drugs, enhancing targeted delivery in therapeutic applications. Additionally, Aminooxy-PEG2-alcohol functions as a PEG-based linker for the synthesis of PROTACs, providing a versatile tool for research in targeted protein degradation and drug development.

Ald-Ph-amido-PEG4-propargyl is a non-cleavable polyethylene glycol (PEG) linker designed for antibody-drug conjugate (ADC) synthesis. This reagent features an alkyne group that enables its use in click chemistry, specifically the copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Its application facilitates the stable attachment of therapeutic agents to antibodies, enhancing the efficacy of targeted cancer therapies.

PC Biotin-PEG3-alkyne is a cleavable antibody-drug conjugate (ADC) linker featuring a three-unit polyethylene glycol (PEG) chain. This linker incorporates an alkyne group that enables click chemistry reactions, specifically copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing compounds. It is designed for the synthesis of ADCs, facilitating targeted drug delivery in various biological research applications.

Boc-gly-PEG3-endo-BCN is a cleavable PEG-based linker designed for targeted protein degradation applications through PROTAC technology. Its biocompatible structure facilitates the synthesis of antibody-drug conjugates (ADCs) by serving as a versatile linker. The presence of a bicyclo[6.1.0]nonyne (BCN) group allows for efficient strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules, making it a valuable reagent for click chemistry in biological research.

Mal-CO-PEG5-NHS ester is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). It comprises a 5-unit polyethylene glycol (PEG) chain that facilitates the conjugation of therapeutic agents to antibodies. This reagent is essential for enhancing the solubility and stability of ADCs, thereby improving their pharmacokinetic profiles and therapeutic efficacy in targeted cancer therapies.

Ald-Ph-amido-PEG2 is a non-cleavable linker designed for antibody-drug conjugates (ADCs). This linker facilitates stable conjugation between antibodies and therapeutic agents, ensuring prolonged circulation and targeted delivery to cancer cells. It is especially useful in the development of ADCs aimed at overcoming challenges related to drug release and bioavailability in therapeutic applications.

THP-SS-PEG1-Boc is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This 1 unit PEG linker features a thiol-sensitive disulfide bond, enabling controlled drug release upon cellular internalization. It is ideal for applications in targeted therapy, improving the delivery and efficacy of therapeutic agents in cancer treatment research.

Acid-PEG3-SS-PEG3-acid is a cleavable linker designed for use in antibody-drug conjugates (ADCs). Comprising six units of polyethylene glycol (PEG) and featuring a disulfide bond, it enables the release of the cytotoxic payload within the target cells. This linker is valuable for enhancing the solubility and stability of ADCs, optimizing their therapeutic efficacy in cancer research and treatment development.

Gly-PEG3-amine is a cleavable linker consisting of a three-unit polyethylene glycol (PEG) chain, specifically designed for use in the synthesis of antibody-drug conjugates (ADCs). This reagent allows for effective drug attachment while facilitating controlled release of the cytotoxic agent in target cells. Gly-PEG3-amine is essential for improving the therapeutic index of ADCs, ensuring precise delivery and enhanced efficacy in various cancer research applications.

N-Boc-Val-Dil-Dap-Doe is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the stable attachment of cytotoxic drugs to monoclonal antibodies, ensuring effective delivery targeting tumor cells. Its biosynthetic applications are crucial in the development of targeted cancer therapies, enhancing therapeutic efficacy while minimizing systemic toxicity.

Mal-PEG2-azide is a polyethylene glycol (PEG) based azide linker specifically designed for antibody-drug conjugate (ADC) synthesis. This compound facilitates efficient conjugation through the click chemistry approach, enabling the formation of stable and targeted ADCs. Mal-PEG2-azide is particularly useful in research applications focused on improving the therapeutic efficacy and selectivity of anticancer agents.

Fmoc-aminooxy-PEG2-NH2 is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features an aminooxy functional group that facilitates selective conjugation to antibody moieties. Its polyethylene glycol (PEG) spacer enhances solubility and stability, making it suitable for various therapeutic applications. This reagent is ideal for researchers focused on developing targeted drug delivery systems in cancer therapy.

DBCO-PEG3-C1-acid is an efficient ADC linker designed to facilitate strain-promoted azide-alkyne click reactions. This reagent serves as a powerful tool in the development of antibody-drug conjugates, enhancing target specificity and therapeutic efficacy. Its biocompatible PEG spacer provides solubility and flexibility, making it ideal for conjugating various cytotoxic agents for targeted cancer therapy applications.

SPDMV-sulfo is a glutathione-cleavable linker designed for antibody-drug conjugates (ADCs). This compound facilitates the release of drug payloads in chemically controlled environments, significantly enhancing therapeutic efficacy. It is particularly valuable in cancer research, where selective targeting and controlled drug delivery are critical for minimizing off-target effects. SPDMV-sulfo enables the development of innovative ADC formulations for improving treatment strategies.

Basivarsen linker is an innovative linker designed for antibody-drug conjugates (ADCs). It facilitates the coupling of a transferrin receptor 1 (TfR1) binding Fab and an antisense oligonucleotide, forming the basis of the antibody-oligonucleotide conjugate (AOC) Zeleciment basivarsen. This conjugate specifically targets mutant nuclear myotonic dystrophy protein kinase (DMPK) RNA, promoting its degradation through RHase H and aiming to correct splicing abnormalities. Basivarsen linker is essential for research into myotonic dystrophy type 1 (DM1) and its therapeutic approaches.

Propargyl-PEG1-SS-alcohol is a cleavable 1 unit PEG linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features an alkyne group that enables it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules, facilitating efficient conjugation. Its application is pivotal in the development of targeted cancer therapies, leveraging ADC technology for enhanced specificity in drug delivery.

Ald-Ph-amido-PEG3-C2-Pfp ester is a non-cleavable antibody-drug conjugate (ADC) linker that incorporates a polyethylene glycol (PEG) moiety. This linker enhances solubility and stability of the conjugate while providing effective attachment to the antibody. It is suitable for use in the development of ADCs, facilitating targeted delivery of therapeutic agents to specific cells and tissues in various cancer research applications.

Mc-Phe-Lys(Boc)-PAB is an antibody-drug conjugate (ADC) linker designed to facilitate the targeted delivery of therapeutic agents. It exhibits key biological activity by enhancing the stability and intracellular release of linked cytotoxic compounds. This reagent is primarily used in the development of ADCs for cancer treatment, allowing for improved efficacy and reduced off-target effects in research applications.

Fmoc-(D-Phe)-OSu is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). It facilitates the coupling between antibodies and cytotoxic drugs, ensuring the selective delivery of therapeutic agents to targeted cells. This compound is essential in the development of ADCs, enhancing their efficacy and stability in research applications related to cancer therapeutics and targeted treatment strategies.